HB Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
ECSS
ATO
HB Wealth Management's ABBV Position: Q2 2026 in Review
HB Wealth Management increased its AbbVie (ABBV) stake by 1.3% in Q2 2026, buying an estimated $389K and bringing the position to 142,911 shares worth $36M. The position accounts for 0.2% of the portfolio, ranked #63.
HB Wealth Management first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- HB Wealth Management held 142,911 shares of AbbVie worth $36M as of Q2 2026.
- HB Wealth Management bought 1,807 AbbVie shares in Q2 2026, an estimated $389K.
- AbbVie made up 0.2% of HB Wealth Management's portfolio in Q2 2026, its #63 holding.
- HB Wealth Management first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
- 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on HB Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.